Pancreatic cancer is a lethal disease because incidence and mortality rates are nearly identical.The 5-year survival rate in Western countries is 4%,the lowest among all types of cancer(1).In China,pancreatic cancer...Pancreatic cancer is a lethal disease because incidence and mortality rates are nearly identical.The 5-year survival rate in Western countries is 4%,the lowest among all types of cancer(1).In China,pancreatic cancer is the sixth leading cause of death from malignant disease,with an overall cumulative 5-year survival rate of 1%to 3%(2,3).展开更多
CRISPR/Cas9 is an adaptive immunity system in bacteria and most archaea(Koonin and Makarova,2009;Horvath and Barrangou,2010).The CRISPR/Cas9 gene editing system is comprised of two key components,a small guide RNA(gRN...CRISPR/Cas9 is an adaptive immunity system in bacteria and most archaea(Koonin and Makarova,2009;Horvath and Barrangou,2010).The CRISPR/Cas9 gene editing system is comprised of two key components,a small guide RNA(gRNA)and a Cas9 endonuclease(Deltcheva etal.,2011;Jineketal.,2012).展开更多
文摘Pancreatic cancer is a lethal disease because incidence and mortality rates are nearly identical.The 5-year survival rate in Western countries is 4%,the lowest among all types of cancer(1).In China,pancreatic cancer is the sixth leading cause of death from malignant disease,with an overall cumulative 5-year survival rate of 1%to 3%(2,3).
基金This work was supported by the Lundbeck Foundation(R219-2016-1375 and R173-2014-1105)the Danish Research Council for Independent Research(DFF-1337-00128 and 9041-00317B)+4 种基金the Sapere Aude Young Research Talent Prize(DFF-1335-00763A)the Innovation Fund Denmark(BrainStem)Aarhus University Strategic Grant(AU-iCRISPR)the Sanming Project of Medicine in Shenzhen(SZ5M201612074)BGIResearch,and Guangdong Provincial Key Laboratory of Genome Read and Write(2017B030301011)。
文摘CRISPR/Cas9 is an adaptive immunity system in bacteria and most archaea(Koonin and Makarova,2009;Horvath and Barrangou,2010).The CRISPR/Cas9 gene editing system is comprised of two key components,a small guide RNA(gRNA)and a Cas9 endonuclease(Deltcheva etal.,2011;Jineketal.,2012).